These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 4938322)
41. What to do when the infant is jaundiced. Wennberg RP Med Times; 1971 Nov; 99(11):172-5 passim. PubMed ID: 4939170 [No Abstract] [Full Text] [Related]
43. Steroid inhibition of glucuronization. Rosta J; Makól Z; Fehér T; Korányi G Acta Paediatr Acad Sci Hung; 1970; 11(1):67-9. PubMed ID: 5506540 [No Abstract] [Full Text] [Related]
44. [Practical procedure in the prophylaxis and therapy of hyperbilirubinemia in the newborn infant]. Kunze W; Joppien HG Z Arztl Fortbild (Jena); 1981 Feb; 75(3):108-10. PubMed ID: 7281734 [No Abstract] [Full Text] [Related]
45. Caution with phenobarbital. Wilson JT Clin Pediatr (Phila); 1971 Dec; 10(12):684-7. PubMed ID: 5168664 [No Abstract] [Full Text] [Related]
46. BREAST-MILK JAUNDICE. REPORT OF EIGHT CASES AND EFFECT OF BREAST FEEDING ON INCIDENCE AND SEVERITY OF UNEXPLAINED HYPERBILIRUBINEMIA. STIEHM ER; RYAN J Am J Dis Child; 1965 Mar; 109():212-6. PubMed ID: 14246066 [No Abstract] [Full Text] [Related]
48. [Secretion of DDT with human milk and its effect on mother and child]. Komarova LI Pediatr Akus Ginekol; 1970; 1():19-20. PubMed ID: 5477829 [No Abstract] [Full Text] [Related]
49. [The pros and cons of luminal teatment of hyperbilirubinemia]. Lüders D Monatsschr Kinderheilkd (1902); 1970 Mar; 118(3):94-102. PubMed ID: 4333560 [No Abstract] [Full Text] [Related]
50. [Hepatic-cell enzyme induction using phenobarbital: applications to the treatment of jaundice]. Nusinovici V; Darnis F; Levy VG; Caroli J Sem Hop Ther; 1976 Mar; 52(3):171-4. PubMed ID: 795031 [No Abstract] [Full Text] [Related]
51. Phenobarbitone and the neonate. Wilson JT Lancet; 1969 Jul; 2(7613):214. PubMed ID: 4183157 [No Abstract] [Full Text] [Related]
52. Drugs and bilirubin. Thaler MM; Schmid R Pediatrics; 1971 May; 47(5):807-10. PubMed ID: 4932040 [No Abstract] [Full Text] [Related]
53. [Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital]. Centa A; Camera G; Piccinini A; De Pietro P; Tomatis C Minerva Pediatr; 1976 Apr; 28(15):911-21. PubMed ID: 11400 [No Abstract] [Full Text] [Related]
54. [Phenobarbital in the pharmacotherapy of neonatal jaundices (a review of the literature)]. Skakun NP; Oleĭnik AN; Skakun GK; Dannik LM Vopr Okhr Materin Det; 1973 Sep; 18(9):36-8. PubMed ID: 4206063 [No Abstract] [Full Text] [Related]
55. On the question of the relationship between breastfeeding and jaundice in the first 5 days of life. Gartner LM Semin Perinatol; 1994 Dec; 18(6):502-9. PubMed ID: 7701352 [No Abstract] [Full Text] [Related]
56. [Prevention of hyperbilirubinemia in premature infants using a combination of two enzyme inductors: phenobarbitol and nikethamide]. Hinkel GK; Kintzel HW; Schwarze R; Händel A Dtsch Gesundheitsw; 1972 Sep; 27(39):1854-7. PubMed ID: 4634399 [No Abstract] [Full Text] [Related]